Research on biomarkers of anti-VEGF-drugs-induced-proteinuria in colorectal cancer patients

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400080492

Enrollment

Unknown

Registered

2024-01-30

Start date

2024-02-01

Completion date

Unknown

Last updated

2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

proteinuria

Interventions

Case group:None

Control group:None

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients who met the pathological diagnosis of colorectal cancer, selected an anti-VEGF regimen and were older than 18 years of age.

Exclusion criteria

Exclusion criteria: Pregnant women, hypertension, chronic kidney diseases, diabetes, heart failure, chronic hepatitis, respiratory diseases, previously treated with EGFr, or VEGF mono-clone antibodies.

Design outcomes

Primary

Measure	Time frame
urine protein;	—

Secondary

Measure	Time frame
Endogenous creatinine clearance rate;Serum creatinine;Blood urea nitrogen ;	—

Countries

China

Contacts

Public ContactLiqun Chen

First Affiliated Hospital of Chongqing Medical University

2843668615@qq.com+86 150 2533 0143

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026